Peptide therapy TikTok claims: what the science actually supports

What did @cstakestren actually say?

The creator's core argument is that peptides are not uniformly safe, that influencers downplay side effects for commission income, and that grouping all peptides together is a mistake. They said "peptides can fucking kill you" and followed it with a real point: "there's peptides that are very mild... there's other peptides that are as potent as anabolic steroids." They also promoted their own free community as the responsible alternative to biased influencer content.

To be fair, this is a more nuanced take than most peptide content on TikTok. The creator is not selling a specific product, not citing a dose, and not claiming miraculous results. That's a low bar, but it clears it. The self-promotion at the end does complicate the "ethical" framing they close with, which we'll address below.

Does the science back this up?

Mostly, yes. The claim that peptides vary wildly in risk profile is accurate and undersupported in popular content. Research on specific peptides shows a spectrum of activity and associated risk that makes blanket safety claims irresponsible in either direction.

BPC-157, for example, has shown tissue-healing effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), but human safety data is limited and it is not FDA-approved for any indication. MK-677, which is often grouped with peptides but is actually a small-molecule secretagogue, has been linked to insulin resistance, edema, and increased cortisol in clinical studies (Nass et al., 2008, Journal of Clinical Endocrinology and Metabolism). CJC-1295 combined with ipamorelin stimulates growth hormone release and carries cardiovascular and oncological risks that are not trivial, particularly with long-term use.

The creator's claim that some peptides are "as potent as anabolic steroids" is an approximation that holds up for compounds like MK-677, which can raise IGF-1 levels substantially. That comparison is not precise but it is not dishonest either.

What did they get wrong (or right)?

They got the core taxonomy right. Peptides are a massive and heterogeneous class of compounds. Comparing GHK-Cu copper peptide, used topically in cosmetics, to a growth hormone secretagogue like ipamorelin as if they belong in the same risk category would be genuinely misleading. The creator correctly pushes back on that flattening.

What they got wrong, or at least left dangerously vague, is the phrase "peptides can kill you." That framing, without context, is more alarming than evidenced. There are no well-documented human fatalities attributed directly to research peptides like BPC-157 or TB-500 in the peer-reviewed literature. The risk is real but it operates through different mechanisms: contamination of unregulated products, improper administration, lack of medical supervision, and unknown long-term effects. Saying "kill you" without specifying those pathways is the same kind of reductive communication they criticize others for doing.

The closing pivot to their own community is also worth flagging. Calling influencers out for using commission codes and then directing viewers to your own content platform follows the same attention funnel, just without a direct product sale attached. That is not inherently wrong, but "that's how you talk about these things ethically" is a self-congratulatory claim that deserves scrutiny.

What should you actually know?

The real issue with the peptide market is not that any single compound is definitively deadly. It is that most peptides being sold online are research chemicals, not pharmaceutical-grade products, and they are being used without clinical supervision, proper sterility protocols, or baseline bloodwork. That is where the danger actually lives.

The FDA has not approved BPC-157, TB-500, CJC-1295, ipamorelin, or most other peptides discussed in this category for human use. Compounded versions exist in a complicated regulatory gray zone. A 2023 FDA guidance update moved to restrict certain compounded peptides including BPC-157 and TB-500 from 503A and 503B compounding pharmacies, citing lack of clinical evidence. If you are considering any peptide therapy, that conversation belongs with a licensed clinician who can order baseline labs, review contraindications, and monitor your response. A TikTok guide or a Skool community, however well-intentioned, does not substitute for that.

• Not all peptides carry the same risk. Topical cosmetic peptides and injectable secretagogues are categorically different.
• Unregulated sourcing is a major risk factor independent of the compound itself.
• Peptide use without medical supervision removes any safety net for adverse reactions.
• IGF-1 elevation from growth hormone secretagogues may have oncological implications with chronic use.